{
    "hands_on_practices": [
        {
            "introduction": "The balance of the Hypothalamic-Pituitary-Thyroid (HPT) axis is a classic example of endocrine negative feedback. This exercise provides a quantitative model to explore what happens to this balance at steady state when the thyroid gland is damaged, as in Hashimoto thyroiditis. By solving a system of equations representing pituitary secretion and thyroid production, you can predict the hallmark laboratory findings of primary hypothyroidism and gain a deeper appreciation for the interconnectedness of the axis .",
            "id": "4798001",
            "problem": "A simplified, steady-state model of the Hypothalamic-Pituitary-Thyroid (HPT) axis captures the pathophysiology of autoimmune thyroid injury such as Hashimoto thyroiditis by reducing the effective thyroid gland secretory capacity. Let $S$ denote serum Thyroid Stimulating Hormone (TSH) concentration and $F$ denote serum free thyroxine (free T4) concentration. The thyroid gland capacity is represented by a dimensionless parameter $G$.\n\nUse the following well-validated physiological bases and model abstractions:\n1. At steady state, thyroid hormone production balances clearance. Over a moderate operating range, thyroidal free T4 output is approximately proportional to TSH and gland capacity, so $F = a\\,G\\,S$, where $a$ is a composite proportionality constant.\n2. Pituitary TSH secretion is inhibited by circulating free T4 via negative feedback that can be captured by a first-order Hill-type hyperbolic form: $S = \\dfrac{b}{1 + \\left(\\dfrac{F}{F_{50}}\\right)^{m}}$, where $b$ is the pituitary drive constant in the absence of feedback, $F_{50}$ is the free T4 concentration producing half-maximal feedback inhibition, and $m$ is the Hill exponent. For small to moderate deviations around euthyroid conditions, take $m=1$.\n\nYou are given the following parameter values chosen to reflect euthyroid calibration before injury:\n- Baseline gland capacity $G_0 = 1$.\n- Thyroid output per TSH per unit gland capacity $a = 8\\,\\mathrm{pmol\\,L^{-1}\\,(mIU\\,L^{-1})^{-1}}$.\n- Pituitary drive constant $b = \\dfrac{62}{15}\\,\\mathrm{mIU\\,L^{-1}}$.\n- Half-inhibition free T4 level $F_{50} = 15\\,\\mathrm{pmol\\,L^{-1}}$.\n- Hill exponent $m = 1$.\n\nAutoimmune thyroid injury is modeled as a reduction in gland capacity: $G_{\\text{new}} = 0.70\\,G_0$. Using the model above and these parameter values, compute the new steady-state values of $S$ and $F$ after this reduction in $G$. Round each value to four significant figures. Express the final TSH in $\\mathrm{mIU\\,L^{-1}}$ and the final free T4 in $\\mathrm{pmol\\,L^{-1}}$.",
            "solution": "The problem requires the calculation of new steady-state concentrations of Thyroid Stimulating Hormone ($S$) and free thyroxine ($F$) following a reduction in thyroid gland capacity ($G$). The physiological system is described by a set of two coupled algebraic equations.\n\nFirst, the problem statement is validated.\n**Step 1: Extracted Givens**\n- Equations of the model:\n  1. $F = a\\,G\\,S$\n  2. $S = \\dfrac{b}{1 + \\left(\\dfrac{F}{F_{50}}\\right)^{m}}$\n- Parameter values for the euthyroid state:\n  - Baseline gland capacity: $G_0 = 1$\n  - Thyroid output constant: $a = 8\\,\\mathrm{pmol\\,L^{-1}\\,(mIU\\,L^{-1})^{-1}}$\n  - Pituitary drive constant: $b = \\dfrac{62}{15}\\,\\mathrm{mIU\\,L^{-1}}$\n  - Half-inhibition concentration: $F_{50} = 15\\,\\mathrm{pmol\\,L^{-1}}$\n  - Hill exponent: $m = 1$\n- Condition of thyroid injury:\n  - New gland capacity: $G_{\\text{new}} = 0.70\\,G_0$\n\n**Step 2: Validation**\nThe problem is scientifically grounded, using a standard simplified model of the Hypothalamic-Pituitary-Thyroid (HPT) axis common in quantitative physiology. The provided equations and parameters are consistent and lead to physiologically realistic baseline values. The problem is well-posed, with a system of two equations for two unknowns, and all necessary information is provided without contradiction. The language is objective and precise. Therefore, the problem is valid.\n\n**Step 3: Solution**\nWe begin by substituting the given parameter values into the model equations.\nThe value of the Hill exponent is $m=1$. The pituitary feedback equation simplifies to:\n$$S = \\dfrac{b}{1 + \\dfrac{F}{F_{50}}}$$\nThe new gland capacity, $G_{\\text{new}}$, is calculated as:\n$$G_{\\text{new}} = 0.70\\,G_0 = 0.70 \\times 1 = 0.70$$\nThe system of equations that defines the new steady state is:\n1. $F = a\\,G_{\\text{new}}\\,S$\n2. $S = \\dfrac{b}{1 + \\dfrac{F}{F_{50}}}$\n\nWe have the following parameter values:\n$a = 8$\n$b = \\dfrac{62}{15}$\n$F_{50} = 15$\n$G_{\\text{new}} = 0.70$\n\nSubstituting these values into the system of equations yields:\n1. $F = 8 \\times 0.70 \\times S = 5.6\\,S$\n2. $S = \\dfrac{62/15}{1 + F/15}$\n\nWe can solve this system by substitution. From equation (1), we express $S$ in terms of $F$:\n$$S = \\dfrac{F}{5.6}$$\nNow, we substitute this expression for $S$ into equation (2):\n$$\\dfrac{F}{5.6} = \\dfrac{62/15}{1 + F/15}$$\nTo simplify the right-hand side, we find a common denominator in the denominator:\n$$\\dfrac{F}{5.6} = \\dfrac{62/15}{\\dfrac{15+F}{15}} = \\dfrac{62}{15+F}$$\nNext, we cross-multiply to eliminate the denominators:\n$$F(15 + F) = 5.6 \\times 62$$\n$$15F + F^2 = 347.2$$\nRearranging this into the standard form of a quadratic equation ($ax^2 + bx + c = 0$):\n$$F^2 + 15F - 347.2 = 0$$\nWe solve for $F$ using the quadratic formula, $F = \\dfrac{-B \\pm \\sqrt{B^2 - 4AC}}{2A}$, with coefficients $A=1$, $B=15$, and $C=-347.2$.\n$$F = \\dfrac{-15 \\pm \\sqrt{15^2 - 4(1)(-347.2)}}{2(1)}$$\n$$F = \\dfrac{-15 \\pm \\sqrt{225 + 1388.8}}{2}$$\n$$F = \\dfrac{-15 \\pm \\sqrt{1613.8}}{2}$$\nThe numerical value of the square root is approximately $\\sqrt{1613.8} \\approx 40.172129$.\nThis gives two possible solutions for $F$:\n$$F_1 = \\dfrac{-15 + 40.172129}{2} = \\dfrac{25.172129}{2} \\approx 12.5860645$$\n$$F_2 = \\dfrac{-15 - 40.172129}{2} = \\dfrac{-55.172129}{2} \\approx -27.5860645$$\nSince the concentration of free thyroxine ($F$) must be a non-negative physical quantity, we select the apositive root:\n$$F \\approx 12.5860645\\,\\mathrm{pmol\\,L^{-1}}$$\nThe problem requires the answer to be rounded to four significant figures.\n$$F \\approx 12.59\\,\\mathrm{pmol\\,L^{-1}}$$\nNow, we can find the corresponding steady-state TSH concentration, $S$, using the relation $S = \\dfrac{F}{5.6}$. Using the unrounded value of $F$ for better accuracy:\n$$S = \\dfrac{12.5860645}{5.6} \\approx 2.2475115\\,\\mathrm{mIU\\,L^{-1}}$$\nRounding this value to four significant figures gives:\n$$S \\approx 2.248\\,\\mathrm{mIU\\,L^{-1}}$$\nThe new steady-state values are a TSH concentration of approximately $2.248\\,\\mathrm{mIU\\,L^{-1}}$ and a free T4 concentration of approximately $12.59\\,\\mathrm{pmol\\,L^{-1}}$. These results are consistent with the pathophysiology of primary hypothyroidism, where decreased thyroid function leads to a lower free T4 level and a compensatory rise in TSH.",
            "answer": "$$\\boxed{\\begin{pmatrix} 2.248 & 12.59 \\end{pmatrix}}$$"
        },
        {
            "introduction": "While the previous exercise established that TSH rises when free T4 falls, the *magnitude* of this response is a critical feature of the HPT axis. This practice delves into the high sensitivity of the pituitary's negative feedback, which is often approximated by a log-linear relationship. Calculating the fold-change in TSH from a small drop in free T4 will demonstrate why TSH is such a powerful screening tool for early or subclinical thyroid dysfunction .",
            "id": "4798053",
            "problem": "A patient with autoimmune Hashimoto thyroiditis develops a reduction in circulating free thyroxine (free $\\mathrm{T4}$), leading to compensatory changes in pituitary Thyroid Stimulating Hormone (TSH) secretion via negative feedback. Near the euthyroid set point, experimental data suggest a locally log-linear relationship between serum TSH and free $\\mathrm{T4}$ such that the local slope of $\\log_{10}(\\mathrm{TSH})$ with respect to free $\\mathrm{T4}$ is approximately constant.\n\nAssume that, over a small interval near the set point, the local sensitivity is given by a slope of $-0.4$ in $\\log_{10}(\\mathrm{TSH})$ per pmol/L of free $\\mathrm{T4}$. The patientâ€™s free $\\mathrm{T4}$ decreases from $16$ pmol/L to $12$ pmol/L. Using the local linear approximation of the negative feedback response, calculate the expected fold-change in serum TSH, defined as the ratio of the final TSH to the initial TSH. Express your answer as a dimensionless number and round your result to three significant figures.",
            "solution": "The problem statement has been validated and is deemed scientifically grounded, well-posed, and objective. It provides a quantitative model of the negative feedback relationship between free thyroxine (free $\\mathrm{T4}$) and Thyroid Stimulating Hormone (TSH) within a pathophysiological context.\n\nLet $C_{T4}$ represent the concentration of free thyroxine in pmol/L, and let $C_{TSH}$ represent the concentration of serum TSH. The problem states that there is a locally log-linear relationship between $C_{TSH}$ and $C_{T4}$ near the euthyroid set point. Specifically, the slope of $\\log_{10}(C_{TSH})$ with respect to $C_{T4}$ is a constant. We can express this using derivative notation:\n$$ \\frac{d(\\log_{10}(C_{TSH}))}{dC_{T4}} = m $$\nwhere the slope $m$ is given as $-0.4$ (in units of $\\log_{10}(\\mathrm{TSH})$ units per pmol/L).\n\nThe problem asks for the fold-change in TSH when $C_{T4}$ decreases. We are instructed to use a local linear approximation. For a finite change in $C_{T4}$, denoted by $\\Delta C_{T4}$, the corresponding change in the function $\\log_{10}(C_{TSH})$, denoted by $\\Delta(\\log_{10}(C_{TSH}))$, can be approximated as:\n$$ \\Delta(\\log_{10}(C_{TSH})) \\approx m \\cdot \\Delta C_{T4} $$\n\nLet the initial and final states be denoted by subscripts $i$ and $f$, respectively.\nThe initial free T4 concentration is $C_{T4,i} = 16$ pmol/L.\nThe final free T4 concentration is $C_{T4,f} = 12$ pmol/L.\n\nFirst, we calculate the change in the free T4 concentration, $\\Delta C_{T4}$:\n$$ \\Delta C_{T4} = C_{T4,f} - C_{T4,i} = 12 - 16 = -4 \\text{ pmol/L} $$\n\nNext, we use the linear approximation to find the change in $\\log_{10}(C_{TSH})$:\n$$ \\Delta(\\log_{10}(C_{TSH})) \\approx (-0.4) \\cdot (-4) $$\n$$ \\Delta(\\log_{10}(C_{TSH})) \\approx 1.6 $$\n\nThe change $\\Delta(\\log_{10}(C_{TSH}))$ is defined as the difference between the final and initial values of the logarithm of TSH concentration:\n$$ \\Delta(\\log_{10}(C_{TSH})) = \\log_{10}(C_{TSH,f}) - \\log_{10}(C_{TSH,i}) $$\nUsing the property of logarithms, $\\log(a) - \\log(b) = \\log(a/b)$, we can rewrite this as:\n$$ \\log_{10}(C_{TSH,f}) - \\log_{10}(C_{TSH,i}) = \\log_{10}\\left(\\frac{C_{TSH,f}}{C_{TSH,i}}\\right) $$\n\nThe term $\\frac{C_{TSH,f}}{C_{TSH,i}}$ represents the fold-change in serum TSH, which is the quantity we need to calculate.\nCombining our results, we have:\n$$ \\log_{10}\\left(\\frac{C_{TSH,f}}{C_{TSH,i}}\\right) \\approx 1.6 $$\n\nTo find the fold-change itself, we must take the antilogarithm (base $10$) of both sides of the equation:\n$$ \\frac{C_{TSH,f}}{C_{TSH,i}} \\approx 10^{1.6} $$\n\nNow, we evaluate this expression numerically:\n$$ 10^{1.6} = 10^{1} \\times 10^{0.6} \\approx 39.810717... $$\n\nThe problem requires the answer to be rounded to three significant figures. The first three significant figures are $3$, $9$, and $8$. The fourth digit is $1$, which is less than $5$, so we round down.\nThe calculated fold-change in serum TSH is approximately $39.8$. This significant increase in TSH is the expected physiological compensatory response to a drop in circulating thyroid hormone.",
            "answer": "$$\\boxed{39.8}$$"
        },
        {
            "introduction": "Managing hypothyroidism with hormone replacement requires maintaining stable free T4 levels, but this is complicated by physiological changes that alter drug pharmacokinetics and protein binding. This problem simulates a common clinical challenge: adjusting levothyroxine dosage during pregnancy, when increased thyroxine-binding globulin (TBG) levels can disrupt the free hormone concentration. By applying principles of clearance, bioavailability, and binding equilibrium, you can calculate the necessary dose adjustment to ensure the patient remains euthyroid .",
            "id": "4797995",
            "problem": "A patient with Hashimoto thyroiditis is clinically hypothyroid without endogenous thyroid hormone production and maintained at a stable pre-pregnancy thyroid-stimulating hormone (TSH) by daily oral levothyroxine. In early pregnancy, estrogen-induced hepatic changes increase thyroxine-binding globulin (TBG), altering the free fraction of thyroxine available to the pituitary. Using core pharmacokinetic and binding definitions, determine the adjusted levothyroxine dose required to maintain the pre-pregnancy free thyroxine concentration and thus the same TSH setpoint when TBG rises by $50\\%$.\n\nAssume the following scientifically plausible parameters:\n- Pre-pregnancy daily levothyroxine dose is $D_{0} = 100$ micrograms per day with oral bioavailability $F_{0} = 0.80$ and systemic clearance $CL_{0} = 1.20$ liters per day.\n- Early pregnancy changes lead to $F_{1} = 0.76$ and $CL_{1} = 1.50$ liters per day due to maternal physiological adaptations.\n- The dosing interval is $\\tau = 1$ day, and steady state has been achieved in both conditions.\n- The effective binding of thyroxine to serum proteins can be approximated by a single-site equilibrium capturing the dominant contribution of thyroxine-binding globulin (TBG) and other binding proteins through an effective association parameter $K_{\\text{eff}}$ such that the free fraction is $f_{u} = \\frac{1}{1 + K_{\\text{eff}} [\\text{TBG}]}$.\n- Pre-pregnancy TBG concentration is $[\\text{TBG}]_{0} = 20$ milligrams per liter and the effective association parameter is $K_{\\text{eff}} = 250$ liters per milligram. Early pregnancy increases TBG by $50\\%$, so $[\\text{TBG}]_{1} = 30$ milligrams per liter.\n\nStarting from the definitions of clearance, bioavailability, steady-state mass balance, and reversible binding, derive the levothyroxine dose $D_{1}$ that maintains the pre-pregnancy average free thyroxine concentration. Round your final dose to three significant figures and express it in micrograms per day.",
            "solution": "The problem requires the determination of an adjusted oral levothyroxine dose, $D_1$, during early pregnancy to maintain the same average free thyroxine concentration, $[C_{free}]_{avg}$, as in the pre-pregnancy state. The patient has no endogenous thyroid hormone production, so the entirety of circulating thyroxine is from the exogenous dose.\n\nThe analysis begins with the fundamental principles of pharmacokinetics at steady state. For a drug administered orally at a constant daily dose, the average total concentration at steady state, $[C_{total}]_{avg}$, is determined by the rate of drug administration and the systemic clearance. The rate of administration is the product of the dose, $D$, and its oral bioavailability, $F$, divided by the dosing interval, $\\tau$. The rate of elimination is the product of the clearance, $CL$, and the average concentration, $[C_{total}]_{avg}$. At steady state, these rates are equal:\n\n$$CL \\cdot [C_{total}]_{avg} = \\frac{F \\cdot D}{\\tau}$$\n\nSolving for the average total concentration gives:\n\n$$[C_{total}]_{avg} = \\frac{F \\cdot D}{CL \\cdot \\tau}$$\n\nThyroxine is highly bound to plasma proteins, primarily thyroxine-binding globulin (TBG). The physiologically active component is the free, unbound hormone. The relationship between the average free concentration, $[C_{free}]_{avg}$, and the average total concentration, $[C_{total}]_{avg}$, is defined by the unbound fraction, $f_u$:\n\n$$[C_{free}]_{avg} = f_u \\cdot [C_{total}]_{avg}$$\n\nSubstituting the expression for $[C_{total}]_{avg}$ into this equation yields the governing expression for the average free concentration at steady state:\n\n$$[C_{free}]_{avg} = f_u \\cdot \\left(\\frac{F \\cdot D}{CL \\cdot \\tau}\\right)$$\n\nThe clinical goal is to maintain the same average free thyroxine concentration in early pregnancy (state $1$) as was present pre-pregnancy (state $0$). This establishes the core equality for solving the problem:\n\n$$[C_{free}]_{avg, 1} = [C_{free}]_{avg, 0}$$\n\nUsing the derived equation for $[C_{free}]_{avg}$ for both states, we have:\n\n$$f_{u,1} \\cdot \\left(\\frac{F_1 \\cdot D_1}{CL_1 \\cdot \\tau}\\right) = f_{u,0} \\cdot \\left(\\frac{F_0 \\cdot D_0}{CL_0 \\cdot \\tau}\\right)$$\n\nSince the dosing interval $\\tau$ is the same in both states ($\\tau=1$ day), it cancels from the equation. We can now solve for the required early pregnancy dose, $D_1$:\n\n$$D_1 = D_0 \\cdot \\left(\\frac{F_0}{F_1}\\right) \\cdot \\left(\\frac{CL_1}{CL_0}\\right) \\cdot \\left(\\frac{f_{u,0}}{f_{u,1}}\\right)$$\n\nNext, we must evaluate the ratio of the unbound fractions, $f_{u,0}/f_{u,1}$. The problem provides the relationship between $f_u$, the effective association parameter $K_{\\text{eff}}$, and the TBG concentration $[\\text{TBG}]$:\n\n$$f_u = \\frac{1}{1 + K_{\\text{eff}}[\\text{TBG}]}$$\n\nUsing this definition, we can express the ratio $f_{u,0}/f_{u,1}$ as:\n\n$$\\frac{f_{u,0}}{f_{u,1}} = \\frac{\\frac{1}{1 + K_{\\text{eff}}[\\text{TBG}]_0}}{\\frac{1}{1 + K_{\\text{eff}}[\\text{TBG}]_1}} = \\frac{1 + K_{\\text{eff}}[\\text{TBG}]_1}{1 + K_{\\text{eff}}[\\text{TBG}]_0}$$\n\nSubstituting this expression back into the equation for $D_1$ gives the final symbolic solution:\n\n$$D_1 = D_0 \\cdot \\left(\\frac{F_0}{F_1}\\right) \\cdot \\left(\\frac{CL_1}{CL_0}\\right) \\cdot \\left(\\frac{1 + K_{\\text{eff}}[\\text{TBG}]_1}{1 + K_{\\text{eff}}[\\text{TBG}]_0}\\right)$$\n\nWe now substitute the given numerical values into this equation. The parameters are:\n- Pre-pregnancy dose: $D_0 = 100$ micrograms per day\n- Bioavailability: $F_0 = 0.80$ (pre-pregnancy), $F_1 = 0.76$ (early pregnancy)\n- Clearance: $CL_0 = 1.20$ L/day (pre-pregnancy), $CL_1 = 1.50$ L/day (early pregnancy)\n- Effective association parameter: $K_{\\text{eff}} = 250$ L/mg\n- TBG concentration: $[\\text{TBG}]_0 = 20$ mg/L (pre-pregnancy), $[\\text{TBG}]_1 = 30$ mg/L (early pregnancy)\n\nFirst, we calculate the terms in the unbound fraction ratio:\n$$K_{\\text{eff}}[\\text{TBG}]_0 = 250 \\frac{\\text{L}}{\\text{mg}} \\times 20 \\frac{\\text{mg}}{\\text{L}} = 5000$$\n$$K_{\\text{eff}}[\\text{TBG}]_1 = 250 \\frac{\\text{L}}{\\text{mg}} \\times 30 \\frac{\\text{mg}}{\\text{L}} = 7500$$\n\nNow, we substitute all values into the equation for $D_1$:\n\n$$D_1 = 100 \\cdot \\left(\\frac{0.80}{0.76}\\right) \\cdot \\left(\\frac{1.50}{1.20}\\right) \\cdot \\left(\\frac{1 + 7500}{1 + 5000}\\right)$$\n\n$$D_1 = 100 \\cdot \\left(\\frac{0.80}{0.76}\\right) \\cdot \\left(\\frac{1.50}{1.20}\\right) \\cdot \\left(\\frac{7501}{5001}\\right)$$\n\nCalculating the value of the expression:\n\n$$D_1 = 100 \\cdot (1.052631...) \\cdot (1.25) \\cdot (1.499900...)$$\n\n$$D_1 \\approx 197.35515$$\n\nThe problem requires the final dose to be rounded to three significant figures.\n\n$$D_1 \\approx 197 \\text{ micrograms per day}$$",
            "answer": "$$\\boxed{197}$$"
        }
    ]
}